Breakthrough Therapy Designation recently granted in the US for Enhertu in this setting
Attachments
- Original document
- Permalink
Disclaimer
AstraZeneca plc published this content on 29 May 2020 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 29 May 2020 12:05:03 UTC